Loading stock data…
Loading stock data…
US$1.60
Get one email when NMRA crosses your level. Checked every 15 minutes during market hours.
▼ -0.03 (-1.84%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
47.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.03
Bullish momentumMACD above its signal line (-0.03).
50-day average
1.72
Price belowShort-term trend reference.
200-day average
2.19
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing precision medicines for brain diseases. The company concentrates on neuropsychiatric and neurodegenerative disorders, using a data-driven neuroscience platform that integrates clinical, translational, and computational tools to better define patient subtypes and underlying disease biology. Neumora’s pipeline currently includes seven clinical and preclinical programs that target novel mechanisms of action a…
www.neumoratx.com5 strong buy · 7 buy · 2 hold · 1 sell · 0 strong sell (15 analysts, 2026-07-01)
5 strong buy · 7 buy · 2 hold · 1 sell · 0 strong sell (15 analysts, 2026-06-01)
5 strong buy · 7 buy · 2 hold · 1 sell · 0 strong sell (15 analysts, 2026-05-01)
5 strong buy · 7 buy · 2 hold · 1 sell · 0 strong sell (15 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-09 | 0.48 | 0.22 | ✗ Miss |
| 2026-05-07 | -0.31 | -0.3 | ✓ Beat |
| 2026-03-30 | -0.33 | -0.35 | ✗ Miss |
| 2026-03-02 | -0.54 | -0.7 | ✗ Miss |
| 2026-01-15 | 2.98 | 3.14 | ✓ Beat |
| 2025-11-06 | -0.34 | -0.35 | ✗ Miss |
| 2025-10-23 | -0.3 | -0.19 | ✓ Beat |
Companies in the same industry, via Finnhub